Departamento de Psicobiologia, Universidade Federal de Sao Paulo, São Paulo, Brasil.
Departamento de Pneumologia, Universidade Federal de Sao Paulo, São Paulo, Brasil.
J Clin Sleep Med. 2021 Feb 1;17(2):149-158. doi: 10.5664/jcsm.8822.
To evaluate and compare the effects of continuous positive airway pressure (CPAP), use of a mandibular advancement device (MAD), and no treatment on 24-hour ambulatory blood pressure monitoring and peripheral arterial tonometry at 6 and 12 months follow-up in individuals with mild obstructive sleep apnea (OSA), and in a subgroup who had an apnea-hypopnea index of < 5 events/h and adherence of ≥ 4 hours per night (effective-treatment subgroups).
The inclusion criteria were individuals with mild obstructive sleep apnea, any sex, age between 18 and 65 years, and a body mass index of ≤ 35 kg/m². Patients were randomized into CPAP, MAD, and no-treatment groups. The evaluations included physical examination, full polysomnography, 24-hour ambulatory blood pressure monitoring, and peripheral arterial tonometry at baseline and after 6 and 12 months. A generalized linear mixed model was used for comparisons.
The CPAP and MAD groups had lower apnea-hypopnea indexes than the control group at 6 and 12 months, and the CPAP group had higher blood oxygen levels (SpO₂) than the MAD group. The MAD group had more hours of treatment per night and better adaptation to treatment than the CPAP group (MAD: 5.7 ± 2.7 h/night; CPAP: 3.8 ± 3.4 h/night; MAD: 16% did not adapt; CPAP: 42% did not adapt). No differences were found in the total sample and effective treatment in relation to peripheral arterial tonometry or 24-hour ambulatory blood pressure monitoring outcomes.
Treatment of mild obstructive sleep apnea with CPAP or MAD did not improve blood pressure or endothelial function after 1 year, even in patients with effective treatment.
Registry: ClinicalTrials.gov; Name: Continuous Positive Airway Pressure and Oral Appliances Treatments in Mild Obstructive Sleep Apnea; URL: https://clinicaltrials.gov/ct2/show/NCT01461486; Identifier: NCT01461486.
评估和比较持续气道正压通气(CPAP)、使用下颌前伸装置(MAD)和不治疗对轻度阻塞性睡眠呼吸暂停(OSA)患者的 24 小时动态血压监测和外周动脉张力的影响,并在亚组中比较呼吸暂停低通气指数<5 次/小时和每晚≥4 小时依从性(有效治疗亚组)的影响。
纳入标准为轻度阻塞性睡眠呼吸暂停患者,任何性别,年龄 18-65 岁,体重指数≤35kg/m²。患者随机分为 CPAP、MAD 和不治疗组。评估包括体格检查、全夜多导睡眠图、24 小时动态血压监测和外周动脉张力,基线和治疗后 6 个月和 12 个月进行评估。采用广义线性混合模型进行比较。
CPAP 和 MAD 组在 6 个月和 12 个月时呼吸暂停低通气指数低于对照组,CPAP 组血氧水平(SpO₂)高于 MAD 组。MAD 组每晚治疗时间更长,对治疗的适应性更好(MAD:5.7±2.7h/夜;CPAP:3.8±3.4h/夜;MAD:16%不适应;CPAP:42%不适应)。在总样本和有效治疗中,外周动脉张力或 24 小时动态血压监测结果均无差异。
即使在有效治疗的患者中,CPAP 或 MAD 治疗轻度阻塞性睡眠呼吸暂停 1 年后也不能改善血压或内皮功能。
注册号:ClinicalTrials.gov;名称:持续气道正压通气和口腔器具治疗轻度阻塞性睡眠呼吸暂停;网址:https://clinicaltrials.gov/ct2/show/NCT01461486;标识符:NCT01461486。